Does ENCORAFENIB Cause Ejection fraction decreased? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Ejection fraction decreased have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.4% of all adverse event reports for ENCORAFENIB.
32
Reports of Ejection fraction decreased with ENCORAFENIB
0.4%
of all ENCORAFENIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Ejection fraction decreased From ENCORAFENIB?
Of the 32 reports, 10 (31.3%) required hospitalization.
Is Ejection fraction decreased Listed in the Official Label?
Yes, Ejection fraction decreased is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which ENCORAFENIB Alternatives Have Lower Ejection fraction decreased Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN